Net Loss per Share (Tables)

6 Months Ended

Jun. 30, 2025

Earnings Per Share [Abstract]

Schedule of Weighted-Average Common Shares Outstanding

The following securities are the weighted-average common shares outstanding used to calculate basic and diluted net loss per common share:


		Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
Common stock			50,233,281				35,641,878				48,092,928				34,037,201
May 2023 Tranche A pre-funded warrants			-				2,241,352				-				2,325,091
May 2023 Tranche B pre-funded warrants			-				451,632				-				451,632
October 2023 pre-funded warrants			250,000				296,703				250,000				606,044
Total			50,483,281				38,631,565				48,342,928				37,419,968

Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding for the periods presented because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares):


		As of June 30,
		2025				2024
Warrants issued to 2010/2012 convertible note holders to purchase common stock			-				6,804
Warrants issued to underwriter to purchase common stock			-				1,100
March 2022 common warrants			516,265				1,483,743
May 2023 Tranche B warrants			-				5,775,000
Options to purchase common stock			3,468,278				3,305,259
Outstanding restricted stock units			468,457				256,030
Total			4,453,000				10,827,936